Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

Profile

  • Organization
    Center for Genomic Pathology

  • Use Statement - Please enter your reason for creating an NCI Hub account.
    (not set)

  • Reason
    (not set)

  • Biography
    Robert D. Cardiff, M.D., Ph.D.

    Dr. Cardiff is an academic surgical pathologist who received his bachelor’s degree (entomology) and Ph.D. (zoology) from UC Berkeley and his MD degree from UCSF. His pathology training was at University of.Oregon Medical School, Portland. He has been at University of California, Davis since 1971 where he is a Distinguished Professor and was the Chair of the Department of Pathology from 1990 to 1996, Founding Director of the UCD Center for Medical Informatics and UCD Center for Comparative Medicine’s Mutant Mouse Pathology Facility (MMPF). His research interests have focused on experimental pathology of mouse tumorigenesis. As director of the MMPF, he has developed a digitized archive of samples from over 30,000 mutant mice from over 200 laboratories from 18 countries. Whole slide imaging has allowed him to work with scientists in Europe and throughout the world. This extensive collection serves as a basis for many of his current studies and provides him a unique niche in science as one of the few surgical pathologists in the world who combines a knowledge of R01 funded research, human pathology and mouse tumor pathology. He runs the Pathology Core for the NCI Mouse Models of Human Cancers Consortium and has been the Lead Pathologist for the UC-wide Athena Breast Cancer Research Program. He is the founder and Director of the Center for Genomic Pathology which is devoted to education in comparative pathology. His current research emphasizes mouse models of mammary cancer. Most recently, he has focused attention of the scientific community on the need for comparative pathologists with training required for evaluation of the pending plethora of genetically modified mice.

    Robert D. Cardiff, M.D., Ph.D., Director
    Center for Genomic Pathology
    rdcardiff@ucdavis.edu
    http://ctrgenpath.org